Emanuele Bosi is a physician scientist, Professor of Internal Medicine (formerly of Endocrinology) at the San Raffaele Vita Salute University and Head of the General Medicine, Diabetes and Endocrinology at the San Raffaele Hospital, Milan. Emanuele Bosi graduated in Medicine in 1979 from the University of Milan, Italy, where he also received a specialty diploma in diabetes and metabolic diseases and subsequently in clinical immunology. During his career he has received clinical training in Milan and worked as a clinical investigator at the Edouard Herriot Hospital in Lyon, France, and the University College and St Bartholomew’s Hospitals in London, UK. His research activity has been entirely devoted to diabetes, with focus on pathogenesis, prediction and prevention of type 1 diabetes, new drugs for type 2 diabetes, innovative technologies for blood glucose monitoring and prevention of hypoglycemia. Noteworthy, Dr. Bosi is Principal Investigator of the International TrialNet and INNODIA Clinical Center at the San Raffaele Hospital, conducting intervention trials in recent‐onset type 1 diabetes and in subjects at risk of the disease, as well as further defining the natural history of the disease and its pathophysiology.